최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of cardiology, v.118 no.2, 2007년, pp.173 - 177
AbstractBackgroundStatins are known to possess antioxidant properties in addition to their cholesterol-lowering effects. However, recent studies have suggested that statins reduce the levels of antioxidant vitamins such as vitamin E and coenzyme Q10, possibly resulting in impaired left ventricular f...
Cardiovasc Res Lefer 49 281 2001 10.1016/S0008-6363(00)00247-9 Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease
Atherosclerosis Inoue 160 369 2002 10.1016/S0021-9150(01)00585-8 Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients
Atherosclerosis Hussein 128 11 1997 10.1016/S0021-9150(96)05972-2 Reduced susceptibility of low density lipoprotein [LDL] to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL
Coron Artery Dis Deskur-Smielecka 12 143 2001 10.1097/00019501-200103000-00008 The influence of short-term treatment with simvastatin on the inflammatory profile of patients with hypercholesterolemia
PNAS Tribble 91 1183 1994 10.1073/pnas.91.3.1183 Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content
PNAS Folkers 87 8931 1990 10.1073/pnas.87.22.8931 Lovastatin decreases coenzyme Q levels in humans
Ann Med Vasankari 36 618 2004 10.1080/07853890410018844 Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations
Int J Vitam Nutr Res Jakob 65 31 1995 Rapid HPLC-Assay for assessment of vitamin K1, A, E and beta-carotene status in children (7-19 years)
Ann Clin Biochem Thurnham 23 14 1986 10.1177/000456328602300505 The use of different lipids to express serum tocopherol/lipid ratios for the measurement of vitamin E status
Ann N Y Acad Sci Horwitt 203 223 1972 10.1111/j.1749-6632.1972.tb27878.x Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy
Chem Pharm Bull Suzumura 47 1010 1999 10.1248/cpb.47.1010 An in vitro study of the hydroxyl radical scavenging property of fluvastatin, an HMG-CoA reductase inhibitor
Eur J Pharmacol Yamamoto 361 143 1998 10.1016/S0014-2999(98)00692-X Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes
Biochim Biophys Acta Giroux 1165 335 1993 10.1016/0005-2760(93)90145-Y Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
Free Radic Biol Med Pereira 37 1440 2004 10.1016/j.freeradbiomed.2004.07.019 Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients
J Clin Pharmacol Ghirlanda 33 226 1993 10.1002/j.1552-4604.1993.tb03948.x Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study
J Clin Pathol Watts 46 1055 1993 10.1136/jcp.46.11.1055 Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin
Eur J Clin Pharmacol Laaksonen 46 313 1994 10.1007/BF00194398 Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors
JAMA Jula 287 598 2002 10.1001/jama.287.5.598 Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial
Arch Neurol Rundek 61 889 2004 10.1001/archneur.61.6.889 Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke
Clin Chim Acta Human 263 67 1997 10.1016/S0009-8981(97)06557-1 The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia
Am J Cardiol Salonen 76 34-39C 1995 10.1016/S0002-9149(99)80468-8 The Kupio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerostic progression
Eur J Clin Invest Colquhoun 35 251 2005 10.1111/j.1365-2362.2005.01486.x Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans
Am J Cardiol Silver 94 1306 2004 10.1016/j.amjcard.2004.07.121 Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction
Circulation Fukuta 112 357 2005 10.1161/CIRCULATIONAHA.104.519876 Statin therapy may be associated with lower mortality in patients with diastolic heart failure
※ AI-Helper는 부적절한 답변을 할 수 있습니다.